SPL 1.08% 9.4¢ starpharma holdings limited

Ann: Response to media article, page-34

  1. 2,065 Posts.
    lightbulb Created with Sketch. 304
    it would have been far more likely to have been approved if it also had full human testing to back up its lack of toxicity or unanticipated side effects. (And yes, that is clearly possible to do.) That would have cost money, and SPL did not want to spend the money there.

    @BobF
    that's what the trials they conducted in Perth last year were for.

    They haven't done human trials for efficacy because they are simply too clever by half.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $829 8.824K

Buyers (Bids)

No. Vol. Price($)
1 249999 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 50000 1
View Market Depth
Last trade - 12.01pm 08/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.